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Abstract
Background: The COP9/signalosome (CSN) is a highly conserved eight subunit complex that, by
deneddylating cullins in cullin-based E3 ubiquitin ligases, regulates protein degradation. Although
studied in model human cell lines such as HeLa, very little is known about the role of the CSN in
haemopoietic cells.
Results: Greater than 95% knockdown of the non-catalytic subunit CSN2 and the deneddylating
subunit CSN5 of the CSN was achieved in the human myeloid progenitor cell line K562. CSN2
knockdown led to a reduction of both CSN5 protein and mRNA whilst CSN5 knockdown had little
effect on CSN2. Both knockdowns inhibited CSN deneddylase function as demonstrated by
accumulation of neddylated Cul1. Furthermore, both knockdowns resulted in the sequential loss
of Skp2, Cdc4 and β-TrCP F-box proteins. These proteins were rescued by the proteasome
inhibitor MG132, indicating the autocatalytic degradation of F-box proteins upon loss of CSN2 or
CSN5. Interestingly, altered F-box protein gene expression was also observed in CSN2 and CSN5
knockdowns, suggesting a potential role of the CSN in regulating F-box protein transcription.
Loss of either CSN subunit dramatically reduced cell growth but resulted in distinct patterns of cell
death. CSN5 knockdown caused mitotic defects, G2/M arrest and apoptotic cell death. CSN2
knockdown resulted in non-apoptotic cell death associated with accumulation of both the
autophagy marker LC3-II and autophagic vacuoles. Treatment of vector control K562 cells with the
autophagy inhibitors 3-methyladenine and bafilomycin A1 recapitulated the growth kinetics,
vacuolar morphology and LC3-II accumulation of CSN2 knockdown cells indicating that the cellular
phenotype of CSN2 cells arises from autophagy inhibition. Finally, loss of CSN2 was associated with
the formation of a CSN5 containing subcomplex.
Conclusion: We conclude that CSN2 is required for CSN integrity and the stability of individual
CSN subunits, and postulate that CSN2 loss results in a phenotype distinct from that of cells lacking
CSN5 possibly as a consequence of altered CSN5 activity within a resultant CSN subcomplex. Our
data present the first evidence for the sequential loss of F-box proteins upon CSN manipulation
and are the first to identify a potential link between CSN function and autophagy.
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Background
The regulated expression and degradation of proteins are
critical to all aspects of cell development and prolifera-
tion. The two main routes for eukaryotic intracellular pro-
tein clearance are the ubiquitin-proteasome system (UPS)
and the autophagy-lysosome pathway. A key component
involved in regulating degradation of proteins by the UPS
is the COP9 signalosome (CSN). The CSN is an eight-sub-
unit (CSN1-8) protein complex, highly conserved
amongst eukaryotes [1-5] originally identified in Arabi-
dopsis as a negative regulator of photomorphogenesis [6].
Through its function in the regulation of the UPS, the CSN
has been implicated in the regulation of biological proc-
esses as diverse as DNA replication and repair, cell-cycle
progression and cell development [7-9].
Degradation of cellular proteins by the 26S proteasome
[10-13] is preceded by ubiquitination of target proteins
[14], a process mediated by three enzyme complexes; a
ubiquitin activating enzyme (E1), a ubiquitin conjugating
enzyme (E2) and a ubiquitin ligase (E3) [15]. The E3
ligase interacts with the protein substrate and thus confers
the specificity of the UPS [16]. The largest known class of
E3 ubiquitin ligases comprises the Cullin-RING ligases
(CRLs) of which the best studied is the SCF (Skp1, Cul1,
F-box protein) complex [16]. The cullin subunit (Cul1) of
the SCF forms a scaffold to recruit and bring into close
proximity the E2 and its substrate, thereby facilitating
ubiquitin transfer from the E2 to target proteins (SCF
structure reviewed in [16]). The RING protein (Hrt1/
Roc1/Rbx1) is the fourth subunit of the SCF and is respon-
sible for E2 recruitment, whilst the variable F-box protein
subunit, recruited to the SCF complex via the adaptor pro-
tein Skp1, binds substrates selectively [17-19]. In yeast,
over 19 F-box proteins are known, over 400 in A. thaliana,
and ~70 in humans [16]. Since each cullin (Cul1-5) forms
complexes with a variable substrate recognition subunit
(SRS) (F-box proteins for Cul1 as above, VHL box proteins
for Cul2, BTB proteins for Cul3, WD40 proteins for Cul4
and SOCS box proteins for Cul5, reviewed in [20]) specif-
icity in CRL target protein recruitment is achieved by the
large number of variable SRS containing CRLs. It is
thought that, altogether, the human genome may have
the capacity to code for as many as 350 different CRLs.
Given the potential number and diversity of target pro-
teins requiring CRL mediated ubiquitination for degrada-
tion, dynamic regulation of the CRL complex repertoire in
a cell at any given time is essential. All cullins studied
(Cul1-5) have been shown to be modified by neddylation
[21], which facilitates their ubiquitin ligase activity [22]
possibly via increased E2 affinity [23,24]. The deneddyla-
tion of cullins is mediated by the CSN complex [25].
Although initial studies indicated a negative role for
deneddylation, further studies have implicated dened-
dylation in the positive regulation of CRL activity [3,4,26].
It has since been proposed by several groups that optimal
CRL activity requires the cyclic neddylation and dened-
dylation of the cullin subunit [4,7,27]. Although the exact
mechanisms are not fully understood, it is thought that F-
box proteins themselves are targeted for degradation in
part by autoubiquitination within the SCF complex [28].
The deneddylation of cullins by the CSN is believed to
regulate the autoubiquitination of SRSs [28,29], thereby
modulating CRL composition and activity. Furthermore,
the CSN has been shown to be associated with a deubiq-
uitinase activity which may further stabilize autoubiquiti-
nated SRSs [27,29]. The CSN complex is therefore an
integral regulator of CRL activity and subsequent protein
degradation.
In this present study we have investigated the effects of
knocking down CSN2 and CSN5 in the model K562 cell
line, a model of human erythrocyte and megakaryocyte
progenitors [30,31]. Whilst knockdown of either CSN2 or
CSN5 resulted in common changes including the sequen-
tial loss of F-box proteins Skp2, Cdc4 and β-TrCP other
important differences occurred. For example CSN5 knock-
down resulted in apoptotic cell death associated with
aberrant mitosis, whereas CSN2 knockdown cells under-
went non-apoptotic cell death that was associated with
both inhibition of autophagy and the formation of a
novel CSN5 containing CSN subcomplex.
Results
CSN2 and CSN5 knockdown and resulting aberrant SCF 
activity
Plasmids encoding short hairpin RNA (shRNA) to either
CSN2 or CSN5 were electroporated into K562 cells
together with H-2Kk plasmid and transfected cells sorted
by anti- H-2Kk magnetic beads. Three days post transfec-
tion, neither CSN2 nor CSN5 protein could be detected by
western blot analysis in their respective knockdown pro-
tein extracts (Fig. 1A). Furthermore, CSN2 knockdown of
over 99% and CSN5 knockdown of over 95% was
achieved at the mRNA level relative to mock transfectants
as measured by quantitative real-time PCR (QRT-PCR)
(Fig. 1B). This level of knockdown was maintained
throughout the time course of the experiments (data not
shown). Transfection with either the H-2Kk plasmid alone
or co-transfection with H-2Kk plasmid and empty vector
(shVC) had no effect on the level of CSN2 or CSN5 mRNA
or protein relative to mock transfected cells (Fig. 1A &1B
and data not shown). Co-transfections with H-2Kk and a
vector encoding a control scrambled shRNA sequence had
no effect on the level of CSN2 or CSN5 mRNA or protein
relative to cells co-transfected with empty vector (Addi-
tional file 1), demonstrating that the results were specific
and not due to off-target effects.BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31
Page 3 of 12
(page number not for citation purposes)
The instability of particular CSN subunits in the absence
of another subunit has been reported previously. For
example, CSN8 knockdown has been shown to result in
the loss of CSN3, CSN5 and CSN7 protein [32]. We there-
fore determined CSN5 and CSN2 protein levels in CSN2
and CSN5 knockdown cells, respectively, by western blot-
ting. A significant reduction in CSN5 protein was
observed in cells lacking CSN2, whilst depletion of CSN5
had no effect on CSN2 protein or mRNA levels relative to
vector control cells (Fig. 1C and data not shown). Interest-
ingly, CSN2 knockdown not only resulted in loss of CSN5
protein, but also in the significant reduction of CSN5
mRNA as determined by QRT-PCR (Fig. 1D, P = 0.011).
Consistent with previous studies of CSN deregulation
[28,33], both CSN2 and CSN5 knockdowns were associ-
ated with accumulation of neddylated Cul1 (Fig. 1E) indi-
cating functional dysregulation of the CSN following
knockdown of either subunit. Studies demonstrating
Cul1 hyperneddylation in CSN deficient cells have also
demonstrated degradation of the F-box protein Skp2
[28,33]. In agreement with these observations, complete
loss of Skp2 protein was observed in both the CSN2 and
CSN5 knockdown cells (Fig. 1E). Skp2 binds to and medi-
ates the ubiquitination of multiple proteins, including the
cyclin dependent kinase inhibitor p27kip1 [34]. Consistent
with loss of Skp2, knockdown of CSN2 and CSN5
resulted in the accumulation of p27 (Fig. 1E).
Loss of CSN2 and CSN5 results in the sequential loss of F-
box proteins
Skp2 is one of many F-box proteins that can bind to the
Cul1/Roc1/Skp1 complex, thereby altering the substrate
specificity of the SCF (F-box proteins reviewed in [19]).
Analysis of three such F-box proteins, Skp2, Cdc4 and β-
TrCP revealed a sequential loss of protein in CSN2 and
CSN5 knockdown cells (Fig. 2A &2B and Additional file 1,
part D). In CSN2 knockdown cells, Skp2 protein was
reduced by ~60% by day 2 and over 90% by day 6,
whereas Cdc4 was lost at a slower rate with 30–40% lost
by day 3 increasing to ~70% by day 6 (Fig. 2B). Loss of β-
TrCP was still more retarded with ~70% protein remain-
ing at day 6 (Fig. 2B). By day 9, all three F-box proteins
were undetectable in CSN2 knockdown cells (Fig. 2A).
Similar sequential loss of F-box proteins was observed in
CSN5 knockdown cells. At day 4 post transfection Skp2
protein could not be detected, Cdc4 protein was greatly
reduced but remained detectable, and β-TrCP was largely
unaffected (Additional file 1, part D).
In order to determine the mechanism of F-box protein
loss in both CSN2 and CSN5 knockdown cells, we inves-
tigated the rescue of F-box proteins by the proteasome
CSN2 and CSN5 knockdowns result in Cul-1 hyperneddyla- tion, loss of Skp-2 and accumulation of p27 Figure 1
CSN2 and CSN5 knockdowns result in Cul-1 hyper-
neddylation, loss of Skp-2 and accumulation of p27. 
K562 cells were transiently transfected in the absence of 
plasmid DNA (mock), with pMACS Kk.II plasmid alone 
(HKK) or transiently co-transfected with HKK plasmid 
together with either vector control (shVC), CSN2 knock-
down (shCSN2) or CSN5 knockdown (shCSN5) plasmid. 
HKK positive cells were sorted 24 hours post-transfection, 
re-cultured and harvested for analysis. (A) CSN2 (left) and 
CSN5 (right) protein knockdown was determined by west-
ern blot in three independent transfectants. (B) mRNA levels 
in vector control and knockdown cells were determined by 
QRT-PCR (CSN2, left, P = 0.0012; CSN5, right, P = 
0.000031). Data represents 3 independent sets of triplicate 
transfections. (C) CSN5 and CSN2 protein levels were 
determined by western blot in n = 3 CSN2 (top) and CSN5 
(bottom) knockdowns, respectively. (D) CSN5 mRNA levels 
in n = 3 vector control and CSN2 knockdown cells were 
determined by QRT-PCR (P = 0.011). (E) The level of Cul1 
neddylation (top panels, † indicates neddylated Cul-1), Skp2 
protein (second panels) and p27 protein (third panels) was 
determined in n = 3 shCSN2 (left) and shCSN5 (right) sam-
ples by western blot. Even gel loading was determined by β-
actin signal. Graphical data indicates the mean ± s.e.m. * indi-
cates significance with a p value of less than 0.05.
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inhibitor MG132 (Fig. 2C) and measured the levels of F-
box mRNA over time (Fig. 2D &2E). Treatment of both
CSN2 and CSN5 knockdown cells with MG132 resulted
in Skp2, Cdc4 and β-TrCP protein rescue (Fig. 2C), indi-
cating involvement of the proteasome in the loss of these
F-box proteins. However the strength of the observed res-
cue varied. Importantly, CSN subunit depletion also
affected levels of F-box mRNA. CSN2 knockdown resulted
in a significant reduction of Skp2 mRNA by day 2 post
transfection. Thus it is likely that transcriptional changes
also contribute to loss of Skp2 protein in these cells. In
contrast Cdc4 and β-TrCP mRNAs were significantly
increased following CSN2 knockdown despite clear loss
of protein (Fig. 2D). CSN5 depletion resulted in a modest
reduction of all three F-box protein mRNAs but not
enough to account for the observed loss of protein (Fig.
2E). Collectively these data indicate that, with the possi-
ble exception of Skp2 in CSN2 knockdown cells, proteas-
omal degradation rather than transcriptional repression
was the main driver of F-box protein loss in CSN2 and
CSN5 knockdown K562 cells.
Both CSN2 and CSN5 knockdowns result in reduced cell 
growth and cell death
Knockdown of either CSN2 or CSN5 dramatically dimin-
ished cell proliferation, followed by loss of cell viability
(Fig. 3A). Analysis of cumulative growth demonstrated
that proliferation of cells lacking CSN2 was significantly
reduced when compared to that of shVC cells by day 4
post transfection (Fig. 3A, P = 0.034), whilst loss of prolif-
eration following CSN5 knockdown was even more
marked (Fig. 3A insert, P = 0.0023). This difference in
diminished proliferation was corroborated by measure-
ment of thymidine incorporation. At day 3 post-transfec-
tion, there was no significant difference in the
incorporation of tritiated thymidine into cellular DNA
between shVC and CSN2 knockdown (Fig. 3B) whereas
the CSN5 knockdown cells already had markedly reduced
thymidine incorporation (Fig. 3C, P = 0.0012). However,
by day 5 the CSN2 knockdown cells also had a significant
decrease in thymidine incorporation (Fig. 3B, P = 0.0072)
which decreased even further by day 7 (P = 1.1 × 10-5).
Thus, although the changes in Cul1 neddylation and F-
box protein levels are very similar between the CSN2 and
CSN5 knockdowns, differences were apparent in the
growth kinetics of the cells.
Knockdown of CSN5 but not CSN2 is associated with cell 
cycle arrest and defects in mitotic spindle formation
Cell cycle analyses revealed striking differences between
the profiles of CSN2 and CSN5 knockdown cells. Despite
leading to significantly reduced cell proliferation, loss of
CSN2 did not affect the cell cycle distribution of K562
cells as compared to shVC K562 cells by day 6 post trans-
fection (Fig. 4A). Given the significantly reduced cell
numbers in CSN2 knockdown by day 6, this would sug-
gest that these cells are growing more slowly, rather than
arresting at any stage in the cell cycle. In contrast, CSN5
knockdown resulted in a reduction in cells in G1 (25.7%
compared to shVC 35.5%, P = 0.0044), loss of cells from
S phase (21% compared to shVC 45.7%, P = 3.4 × 10-5)
and accumulation in G2/M (33.5% compared to shVC
15.7%, P = 0.0011) by day 4 post transfection (Fig. 4A).
Morphological analysis of Jenner-Giemsa stained CSN5
knockdown cells identified a significant number of large
cells which appeared to be arrested in late mitosis with
chaotically organized condensed chromosomes (Fig. 4B).
Cells of these morphologies were not observed in either
shVC (Fig. 4B) or CSN2 knockdown (Fig. Six A) cells. To
investigate this morphology further, shCSN5 cells were
immunostained for tubulin. As can be seen in Fig. 4C,
shVC cells retained the ability to form a mitotic spindle
and correctly aligned chromosomes at various stages of
mitosis were observed. In striking contrast, cells lacking
CSN5 demonstrated either aberrant or absent microtu-
bule structures. In these cells, the condensed chromatids
appeared to be either misaligned or indeed not associated
with the spindle structures at all (Fig. 4C). This aberrant
cellular phenotype is in accordance with cell cycle arrest at
G2/M.
Knockdown of CSN5 but not CSN2 results in apoptotic cell 
death
In order to determine whether the subsequent loss of via-
bility in CSN2 and CSN5 knockdown cells was due to
apoptosis, cells were co-analysed for annexin V staining
and propidium iodide uptake day 7 and day 6 post trans-
fection, respectively (Fig. 5A). Annexin V binds phos-
phatidylserine, a phospholipid which is translocated from
the inner to the outer leaflet of the plasma membrane dur-
ing early apoptosis. Propidium iodide is taken up by all
cells but is efficiently effluxed by viable cells, whereas
dead/dying cells remain PI-positive. In accordance with
the marked increase in the sub-G1 fraction of shCSN5
cells (Fig. 4A), knockdown of CSN5 lead to significant
increases in both early apoptotic (annexin V+ve:PI-ve) (21.9
± 1.8%, P = 0.0015) and late apoptotic (annexin
V+ve:PI+ve) cells (42.3 ± 2.5%, P = 0.0006) compared to
shVC cells (5.9 ± 1.9% and 5.5 ± 2.2%, respectively; Fig.
5A). Furthermore, CSN5 knockdown cells demonstrated
cleavage of caspase 9 (Fig. 5B), consistent with death by
apoptosis in these cells. In marked contrast, CSN2 knock-
down showed only a relatively small increase in annexin
V positive cells (5.5 ± 0.8% and 12.5 ± 0.9%, respectively;
Fig. 5A) and no caspase 9 activation (Fig. 5B). Instead, the
CSN2 knockdown cells demonstrated increased retention
of PI in the annexin V-ve cell population (Fig. 5C, P = 3.3 ×
10-5). This large shift in PI single-positivity relative to
shVCs was not observed in CSN5 knockdown cells (Fig.
5A &5C). Thus knockdown of CSN2 in K562 cells did not
result in overt apoptosis. Taken together these data indi-
cate that knockdown in K562 cells of CSN5, but notBMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31
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CSN2, resulted in apoptotic cell death and that loss of cell
viability in the CSN2 knockdowns was likely to be by a
non-apoptotic mechanism.
CSN2 but not CSN5 knockdown is associated with 
autophagy
Whilst culturing the transfectants, marked differences in
cell morphology were noted in the CSN2 knockdown
cells. Jenner-Giemsa staining of cytospins identified large
vacuoles in a significant proportion of CSN2 knockdown
cells which were not present in either shVC or shCSN5
cells (Fig. 6A). Staining with the autophagosome/
autophagic vacuole marker monodansylcadaverine
(MDC, [35]) identified these large vacuoles as autophagic
bodies (Fig. 6B). Moreover, western blotting identified a
highly significant accumulation of the autophagy associ-
ated LC3-II protein [36] in CSN2 knockdown cells relative
to shVC cells (Fig. 6C). In contrast, no increase of LC3-II
was detected in CSN5 knockdown cells. To demonstrate
this we used a prolonged exposure (12 hours) of autora-
diographs that allowed detection of basal expression of
LC3-II in shVC cells and demonstrated that this was not
increased in shCSN5 knockdown cells (Fig. 6C). Thus,
knockdown of CSN2, but not CSN5, appeared strongly
associated with autophagy. However, LC3-II accumula-
tion can occur as a result of either enhanced autophagy or
inhibition of autophagy dependant LC3-II degradation
[37]. Indeed, treatment of vector control cells with the
autophagy inhibitor 3-methyladenine (3-MA) resulted in
a growth pattern almost identical to that of shCSN2 cells,
whilst having a relatively small additional effect on
shCSN2 cells (Fig. 6D). Furthermore, treatment of vector
control cells with the late stage autophagy inhibitor
bafilomycin A1 recapitulated both the vacuolar morphol-
ogy (Fig. 6E) and the LC3-II protein accumulation (Fig.
6F) observed in cells lacking CSN2 (Fig. 6A &6C). These
observations suggest that CSN2 knockdown is associated
with the inhibition of autophagy.
Loss of CSN2 results in the formation of an alternative 
CSN5 containing complex
The above data indicate that knockdown of CSN2 or
CSN5 in K562 cells results in common derangement of
SCF activity as measured by accumulation of hyperned-
dylated Cul1, accumulation of p27 and the sequential loss
of Skp-2, cdc4 and β-TrCP. However, the cellular
responses to CSN2 or CSN5 knockdown were markedly
different. Since it has previously been shown that deple-
tion of individual subunits can destabilize the CSN holo-
complex [38-40] we reasoned that one explanation for the
differences between CSN2 and CSN5 knockdown cellular
responses may be due to the generation, in CSN2 knock-
downs, of CSN5 containing CSN subcomplexes with
altered activities. To investigate this, 2-dimensional native
gel electrophoresis was performed on knockdown cells
day 3 post transfection (Fig. 7).
Immunoblotting of extracts from shVC cells with either
CSN2 or CSN5 antibody identified 2 major complexes,
one of approximately 500 KDa, correlating in size with
the CSN holocomplex, and the second of 750 KDa (Fig.
7A &7B). A multitude of proteins have been shown to
associate with CSN subunits [41] and larger complexes
have previously been observed. Monomeric CSN2 and
CSN5 were also observed in the shVC cell extracts (Fig. 7C
Loss of CSN2 and CSN5 results in sequential loss of F-box  proteins Figure 2
Loss of CSN2 and CSN5 results in sequential loss of 
F-box proteins. K562 cells were transiently co-transfected 
with HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and cells re-cultured. (A) shVC and 
shCSN2 cells were harvested day 6 and 9 post transfection 
and the level of Skp2, Cdc4, β-TrCP and β-actin protein 
determined by western blot. (B) The level of Skp2, Cdc4 and 
β-TrCP proteins (normalised for loading using β-actin) in 
shCSN2 at each time point was normalised to expression in 
shVC cells and the data plotted as the mean ± s.e.m. (C) 
shVC, shCSN2 and shCSN5 cells were treated with DMSO 
(control) or the proteasome inhibitor MG132 (10 μM) for 
the final 18 hours of culturing and the level of Skp-2, Cdc4, β-
TrCP and β-actin protein determined by western blot. (D, E) 
The level of Skp2, Cdc4 and β-TrCP mRNA in shCSN2 (D) 
and shCSN5 (E) cells was determined at each time point post 
transfection relative to expression in vector control scram-
ble cells by QRT-PCR. Data shown is the mean ± s.e.m of n 
= 3 transfections. * indicates a significant difference to vector 
controls with a p value of less than 0.05.
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and data not shown). Following knockdown of CSN2,
CSN2 protein was no longer detectable (Fig. 7A). CSN5
protein, as also shown in Fig. 1C, was greatly reduced in
cells lacking CSN2, with significant loss of the CSN com-
plex relative to vector controls (Fig. 7B). Interestingly, a
longer exposure of the autoradiograph identified a CSN5
containing subcomplex of ~242 KDa in cells lacking
CSN2 (Fig. 7C).
Discussion
The achievement of almost complete CSN2 and CSN5
knockdown in this study has provided a powerful tool to
study the function of these CSN subunits more closely. At
the molecular level, CSN2 and CSN5 knockdowns
resulted in aberrant SCF activity, with the accumulation of
neddylated Cul-1, loss of the F-box protein Skp2 and an
increase in the Skp2 target protein, p27. This comple-
ments another report in which CSN4 and CSN5 knock-
down also resulted in increased neddylation of Cul-1 with
a concomitant loss of Skp2 and increase in p27 protein in
human epithelial cell lines rather than haemopoietic cells
[33]. Thus it appears that the CSN complex has highly
conserved activities across cells from different cell lineages
and that disruption of the complex by loss of any subunit
causes derangement of these activities.
It was also observed that CSN2 knockdown not only
results in loss of CSN5 protein but also results in a signif-
icant reduction of CSN5 mRNA. Moreover, both CSN2
and CSN5 knockdown resulted in temporal alterations of
F-box protein mRNA. Together with other recent reports
[32,42], this data suggests that CSN subunits or the CSN
complex as a whole may have a direct role in transcrip-
tional regulation of CSN subunits and F-box proteins.
However, it is also possible that the altered mRNA levels
observed are due to secondary effects of aberrant CRL
mediated protein degradation such as accumulation of
proteins involved in transcriptional regulation.
Here we show for the first time sequential loss of F-box
proteins following knockdown of CSN subunits. Moreo-
ver, protein levels were at least partially restored in both
knockdowns upon treatment with the proteasome inhib-
itor MG132. These observations are in accordance with
the finding that F-box proteins are autocatalytically
degraded in the presence of hyperneddylated Cul-1 [28].
However, the three f-box proteins studied were each lost
at a different rate, with the loss of Skp2 protein being the
most rapid. The sequential loss of F-box proteins is of
great interest as it may explain published results which
document the loss of particular F-box proteins at a specific
time point post CSN manipulation, but no reduction in
other F-box proteins [28,32].
The CSN5 knockdown cultures contained aberrantly large
cells and were associated with G2/M arrest and apoptosis.
This data complements previous studies demonstrating
that CSN5 loss inhibits proliferation and induces apopto-
sis [43-45]. Closer analysis of CSN5 knockdown cells
identified disorganized condensed chromatids and
abnormal mitotic spindles in the large cells. A recent
report described stabilization of the microtubule end-
binding protein 1 (EB1) by the CSN complex in human
cells [46]. EB1, which is a master regulator of microtubule
dynamics, was shown to bind the CSN via CSN5, and was
also shown to be reduced in cells lacking CSN1 or CSN3
[46]. EB1 has recently been shown to directly interact with
and regulate the activity of Aurora B, one essential compo-
nent of the chromosomal passenger complex that is
required for correct chromosomal alignment and spindle
assembly checkpoint [47,48]. Furthermore, the dynamic
behaviour of Aurora B on mitotic chromosomes has been
shown to be regulated by a Cul3 E3 ligase [48]. Given that
we observed hyperneddylated Cul3 in the CSN5 knock-
down cells (data not shown), our data suggests that
CSN5/the CSN complex is integral to the regulation of
multiple components of the mitotic machinery.
K562 cells in which CSN2 had been knocked down did
not display apoptosis markers as in CSN5 knockdown
cells, but were instead associated with features of
autophagy. Interestingly, autophagy inhibitors recapitu-
lated the cell growth kinetics, vacuolar morphology and
LC3-II accumulation of cells lacking CSN2, whilst treat-
ment of CSN2 knockdown cells with one of these inhibi-
tors (3-MA) had a comparatively mild effect on cell
growth. These findings suggest that CSN2 knockdown
K562 cells undergo autophagy inhibition resulting in
non-apoptotic cell death. This is the first data to show an
association between the CSN complex and autophagy.
The distinct phenotypes observed between CSN2 and
CSN5 knockdowns may arise as a result of aberrant CSN5
activity within the observed CSN subcomplex in cells lack-
ing CSN2. However, it is important to note that both the
CSN subunits studied here have CSN independent func-
tions [49-54], and that CSN5 has been shown to function
within a CSN subcomplex in K562 [55]. Therefore, we
cannot rule out the possible contribution of the inde-
pendent functions of CSN2 and CSN5 to the phenotypic
differences observed between the knockdowns. It is also
noteworthy that the subcomplex observed in this study
may be a result of CSN complex breakdown in the
absence of CSN2 [54], rather than a functional complex
contributing to the observed phenotypic differences
between knockdowns. Moreover, as we see no effect of
CSN5 loss on the level of CSN2 protein, one possibility
not investigated here is the formation of a CSN2 contain-
ing subcomplex in the absence of CSN5. This is an intrigu-
ing possibility, particularly given the recent findings of Su
et al who demonstrated an increase in the proportion of
CSN2 residing in mini-complexes upon CSN8 knock-BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31
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down [32]. It will be of great interest to determine the pre-
cise mechanism accounting for the divergent phenotypes
encountered here, and is something which is currently
under investigation.
Conclusion
In conclusion, we have shown that loss of either CSN2 or
CSN5 in human K562 cells results in significant loss of
viability but by very different mechanisms, potentially
attributable to the formation of a CSN5 containing sub-
complex in the absence of CSN2. Furthermore, we have
provided data to suggest a possible function of the CSN
complex in the transcriptional regulation of both its own
components and CRL subunits. Finally, we have demon-
strated here for the first time the sequential loss of F-box
proteins in the absence of the CSN complex and have pro-
vided the first evidence of a link between the CSN com-
plex and autophagy.
Methods
Cell culture and treatments
K562 cells were cultured in RPMI 1640 supplemented
with 100 U/ml penicillin, 100 μg/ml streptomycin and
10% v/v foetal bovine serum (Invitrogen, Gibco) and
maintained at 37°C with 5% CO2. For proteasome inhi-
bition, cells were treated with 10 μM MG132 for the final
18 hours of culturing. For autophagy inhibition, cells
were treated in culture with either 10 mM 3-methylade-
nine from day 3-day 7 post transfection or 1 μM bafilomy-
cin A1 for 48 hours day 5-day 7 post transfection.
shRNA constructs
The shRNA vector used was a modified pcDNA3.1 vector
(pcDNA3.1-H1) developed by Heiko Lickert [56] (kind
gift from Heiner Schrewe) in which the CMV promoter
has been replaced by the human RNAse P RNA H1 pro-
moter [56]. CSN2 and CSN5 silencing sequences were
selected using a siRNA design tool available on
http:www1.qiagen.com/products/genesilencing/custom
siRNA/siRNA designer.aspx and cloned into the Asp718
and XbaI restriction enzyme sites of pcDNA3.1-H1. The
target sequences are as follows:
CSN2 knockdown 5'AAGCGGCATTAAGCAGTTTCC3'
CSN5 knockdown – 5'AAGGGCTACAAACCTCCTGAT3'
shRNA scramble control – 5'AAGCGG GATTCAGTAGT
TACG3'
Transfections and cell sorting
Transfection efficiencies in K562 cells vary between 20–
50%. Therefore, to allow enrichment of transfected cells,
5 × 106 K562 cells were electroporated in Nucleofector kit
V solution (Amaxa) using a Nucleofector I (Amaxa) and
Both CSN2 and CSN5 knockdowns result in reduced cell  growth Figure 3
Both CSN2 and CSN5 knockdowns result in reduced 
cell growth. K562 cells were transiently co-transfected with 
HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and cells re-cultured. (A) Cell counts were 
taken daily and the cumulative growth calculated. The cumu-
lative growth of shCSN2 and shCSN5 cells is shown relative 
to shVC. The insert graph has a different Y scale to highlight 
the differences between shCSN2 and shCSN5 cumulative 
growth profiles. Data shown are the mean ± s.e.m. of n = 3. * 
indicates a significant difference to shVC cell growth with a p 
value of less than 0.05. (B) Thymidine incorporation in 
shCSN2 cells relative to shVC cells was measured day 3, 5 
and 7 post transfection. Data shown are the mean ± s.e.m. of 
n = 3. (C) Thymidine incorporation in shCSN5 cells relative 
to shVC cells was measured day 3 and 4 post transfection. 
Data shown are the mean ± s.e.m. of n = 3. * indicates signif-
icance with a p value of less than 0.05.
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file T16, with 5 μg pMACS Kk.II and 10 μg of the relevant
knockdown pcDNA3.1-H1 plasmid according to manu-
facturer guidelines. The pMACS Kk.II produces a truncated
murine MHC class I cell surface protein, H-2Kk, which
lacks the cytoplasmic domain and is transiently expressed
on the cell surface of transfected cells between 6 and 48
hours post-transfection. Transfected cells were sorted 24
hours post transfection using anti-H-2Kk antibody conju-
gated to magnetic beads, MACS MS columns and a MACS
magnet (Miltenyi Biotec) according to manufacturer
instructions. Post sorting, cells were set at 3 × 105/ml daily
and cells harvested for protein and mRNA analysis as indi-
cated in results.
Thymidine incorporation assay
2 × 104 cells were pulsed with 2 μCi/ml  3H-thymidine
(Amersham) for the final 18 hours of culture leading up
to each time point. Samples were transferred to a filter mat
(Wallac) using a Skatron cell harvester (Skatron Instru-
ments) and read using a beta-plate scintillation counter
(Skatron Instruments).
Immunofluorescence and Jenner-Giemsa staining
Cytospins were made with 5 × 104 cells in 80 μl, using a
Shandon cytospin 3 (Shandon). For immunofluorescence
staining, cytospins were fixed in 4% paraformaldehyde
and stained using anti-β-tubulin antibody (Sigma, 1/500
dilution) followed by FITC labelled secondary antibody
(Jackson Laboratories, 1/500 dilution). DNA was counter-
stained using Hoescht 33342 (Sigma, 1/1000 dilution).
All reagents were diluted in PBS and slides mounted using
Mowiol (6 g glycerol, 2.4 g Moviol-4-88 (Sigma), 12 ml
0.2 M Tris HCl pH8.5, anti-fade crystal (Sigma), 6 ml dis-
tilled water). Slides were viewed using an Axioskop2
microscope (Zeiss) and images captured with a Q-imaging
12-bit QICAM (Media Cybernetics) and Openlab soft-
ware (Improvision).
For Jenner-Giemsa staining, cytospins were air-dried,
methanol fixed and stained; First with Jenner staining
solution (VWR, UK) diluted 1/3 in 1 mM sodium phos-
phate buffer pH5.6 (5 mins) and second with Giemsa
stain (VWR, UK) diluted 1/20 in 1 mM sodium phosphate
buffer pH5.6 (10 mins). Slides were dried and then
mounted onto coverslips using DePex (VWR, UK). Slides
were viewed with an Olympus BX40 microscope (Olym-
pus) and images captured using an Olympus Chameleon
digital SLR (Olympus).
Staining of autophagosomes
For visualisation of autophagic vacuoles, 5 × 104 cells were
incubated with 0.05 mM monodansylcadaverine (MDC,
Sigma) in 0.5 ml PBS for 10 minutes at 37°C. Cells were
washed four times with PBS, cytospins made as above and
cells viewed immediately using a Leica DMIRE2 system.
Fluorescence flow cytometry
For Annexin V labelling, 1 × 105 cells were stained using
Annexin V-FITC Apoptosis Detection Kit I (BD Bio-
sciences) according to manufacturer instructions, and
staining analysed within 1 hour by flow cytometry. For
cell cycle analysis 1 × 105 cells were resuspended in cell
Cell cycle arrest in CSN5 knockdowns is associated with  mitotic defects Figure 4
Cell cycle arrest in CSN5 knockdowns is associated 
with mitotic defects. K562 cells were transiently co-trans-
fected with HKK plasmid together with shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and cells re-cultured. (A) Representative 
images of shCSN2 (left, dark grey line) and shCSN5 (right, 
dark grey line) cell cycle profiles relative to shVC cells (light 
grey fill). Pie charts show data as the mean ± s.e.m. of n = 3. 
* indicates significance with a p value of less than 0.05. (B) 
Cytospins of shVC and shCSN5 cells were stained by Jenner-
Giemsa day 4 post transfection. (C) Cytospins were immu-
nostained for tubulin (FITC) and Hoescht (blue) for visualisa-
tion of DNA in shVC and shCSN5 cells day 4 post 
transfection. All images shown are representative of n = 3 
transfections.
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cycle buffer (10 μg/ml propidium iodide, 0.1 mM sodium
chloride, 1% Triton X100) and samples analysed within
24 hours by flow cytometry. All staining was analysed
using a FACS Calibur (Becton Dickinson) and the data
evaluated using Cell Quest Pro software (Becton Dickin-
son).
Western blot analysis
Whole cell lysates were prepared using RIPA buffer (1% v/
v NP40, 0.5% w/v sodium deoxycholate, 0.1% w/v 10%
SDS, in distilled water) and protein quantified using the
Dc protein assay according to manufacturer instructions
(Bio-Rad). Forty micrograms of protein were boiled for 10
minutes in 1× SDS gel loading buffer (15.6 mM Tris HCl
pH6.8, 6.25% v/v glycerol, 0.5% SDS, 1.25% v/v 2-mer-
captoethanol, Bromophenol Blue, in distilled water). Pro-
teins were separated by SDS-PAGE and transferred to
PVDF membrane (Millipore). For western blot analysis,
the following antibodies were used at 1:1000 dilution:
CSN2 (Bethyl), CSN5 (Bethyl), Cul-1 (Zymed), Skp2
(Zymed), p27 (Santa Cruz), caspase-9 (Cell Signalling),
LC-3 (Novus Biologicals) and β-actin (Sigma). Proteins
recognized by these antibodies were detected using ant-
mouse (Sigma, 1/1000 dilution) or anti-rabbit (Pierce, 1/
1000 dilution) HRP conjugated secondary antibody fol-
lowed by enhanced chemiluminescence (SuperSignal
West Pico Chemiluminescent Substrate, Pierce) and auto-
radiography (Kodak X-Omat LS film, Sigma). Quantita-
tive analysis of western blots was carried out using ImageJ
software http://rsb.info.nih.gov/ij/download.html and
protein levels normalized by comparison to β-actin sig-
nals on the same membrane.
2-Dimensional gel analysis
Native protein extracts were obtained from 2.5 × 105 cells
by resuspending cells in 50 μl mild lysis buffer (25% 4×
NativePAGE sample buffer (Invitrogen), 1% digitonin,
10% 10× protease inhibitor, in distilled water). Extracts
were separated out in the first dimension using a
NativePAGE Novex Bis-Tris Gel System (Invitrogen)
according to manufacturer instructions. The gel was then
cut into individual lanes, proteins denatured by incuba-
tion in 1× SDS gel loading buffer and resolved in the sec-
ond dimension by electrophoresis through 12.5% SDS-
polyacrylamide gels. Proteins were transferred to PVDF
membrane (Millipore) and immunoblotting performed
as above.
Quantitative real-time PCR analysis (QRT-PCR)
RNA was extracted using the Qiagen RNeasy kit according
to manufacturer instructions and cDNA generated using 1
μg RNA, random hexamers (Promega) and Superscript II
reverse transcriptase (Invitrogen). Quantitative real-time
PCR was carried out using either TAQMAN or SYBR-Green
based assays. For TAQMAN assays, QRT-PCR was carried
out in duplicate 20 μl reactions containing 1× qPCR Mas-
termix Plus (Eurogentec), 20–40 ng cDNA, 18 pmoles
each primer and 2.5 pmoles FAM/TAMRA dual labeled
probes. For SYBR-Green assays, QRT-PCR was carried out
in duplicate 25 μl reactions containing 1× Sensimix
(Quantace), 20–40 ng cDNA, 9 pmoles each primer, 1×
SYBR-Green solution (Quantace), 4 mM MgCl2 and 0.5
units UNG (Quantace). QRT-PCR was carried out on an
ABI Prism 7000 sequence detector (Applied Biosystems).
The following primers (Sigma Genosys) and FAM/TAMRA
labeled probes (Eurogentec) were used:
CSN2, 5'-CCTCATCCACTGATTATGGGAGT-3' (forward),
5'-CATCATAATTCTTGAAGGCTTCAAAA-3' (reverse),
CSN5, but not CSN2, knockdown results in apoptotic cell  death Figure 5
CSN5, but not CSN2, knockdown results in apoptotic 
cell death. K562 cells were transiently co-transfected with 
HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and re-cultured. (A) Binding of Annexin V 
and uptake of propidium iodide were analysed by flow 
cytometry. The lower left quadrant encompasses the viable 
population of cells, the lower right quadrant contains early 
apoptotic cells, the upper right quadrant contains late apop-
totic cells and the upper left quadrant contains the necrotic 
cell population. Dot plots shown are representative of n = 3 
transfections. The mean of three data sets was taken and the 
values shown in the corresponding quadrant ± s.e.m. * indi-
cates significance with a p value of less than 0.05. (B) Cells 
were harvested day 6 (shCSN2, top panels) or day 4 
(shCSN5, bottom panels) post transfection and the level of 
caspase-9 cleavage determined by western blot. (C) Propid-
ium iodide uptake was determined day 6 post transfection. 
The histogram shown is representative of n = 3 shVC (light 
grey in fill), shCSN2 (dark grey line) and shCSN5 (black line). 
The significant shift in propidium iodide staining in shCSN2 
cells is shown ± s.e.m. * indicates significance with a p value 
of less than 0.05.
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5'-CCCTCAAGTGCATTTTACCACCACATTCTCT-3'
(probe);
CSN5, 5'-ATATCCGCAGGGAAAG-3' (forward),
5'-GGTCCTTCATCAGGAGGTTTGT-3' (reverse),
5'- TGGCGCCTTTAGGACATACCCAAAGG-3' (probe);
Skp2, 5'-CGCTGCCCACGATCATTT-3' (forward),
5'-CCATGTGCTGTACACGAAAAGG-3' (reverse);
Cdc4, 5'-ACGACGCCGAATTACATCTGT-3' (forward),
5'-ACTCCAGCTCTGAAACATTTTTAGC-3' (reverse);
β-Trcp, 5'-GAGGCATTGCCTGTTTGCA-3' (forward)
5'-TGTCCCATAATCTGATAGTGTTGTCA-3' (reverse)
18S, 5'-GCCGCTAGAGGTGAAATTCTTG-3' (forward),
5'-CATTCTTGGCAAATGCTTTCG-3' (reverse).
Preoptimised primers and probes to 18S ribosomal RNA
were used as internal standards in TAQMAN QRT-PCR
(Applied Biosystems). Cycle threshold (Ct) values were
Loss of CSN2 results in the formation of CSN5 containing  CSN subcomplexes Figure 7
Loss of CSN2 results in the formation of CSN5 con-
taining CSN subcomplexes. K562 cells were transiently 
co-transfected with HKK plasmid together with either shVC 
or shCSN2 plasmid. HKK positive cells were sorted 24 hours 
post-transfection, re-cultured and harvested day 3 post 
transfection. Both CSN2 (A) and CSN5 (B, short exposure; 
C, long exposure) distribution in shVC and shCSN2 cells was 
determined by 2-Dimensional Native-PAGE/SDS-PAGE and 
western blot analysis. All data shown is representative of n = 
3 transfections.
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Cells lacking CSN2, but not CSN5, are associated with  autophagy Figure 6
Cells lacking CSN2, but not CSN5, are associated 
with autophagy. K562 cells were transiently co-transfected 
with HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and re-cultured. (A) Jenner-Giemsa staining 
of shVC and shCSN2 cytospins day 6 post transfection. (B) 
shVC and shCSN2 cells were stained with the autophago-
some marker monodansylcadaverine day 6 post transfection. 
All images shown are representative of n = 3 transfections. 
(C) Cells were harvested day 6 (shCSN2, top panels) or day 
4 (shCSN5, bottom panels) post transfection and the level of 
LC3-II protein determined by western blot. Even loading was 
determined by β-actin signal. (D) Cell counts were taken 
daily and the cumulative growth of shVC cells and shCSN2 
cells +/- 3-MA calculated. The insert has had the untreated 
shVC data removed in order to demonstrate the similarity 
between the shVC +3-MA and shCSN2 cumulative growth 
profiles. Data shown is the mean of n = 3 ± s.e.m. (E) Jenner-
Giemsa staining of shVC +/- 1 μM bafilomycin A1 cytospins 
day 7 post transfection. Images shown are representative of 
n = 3 transfections. (F) Cells were harvested day 7 post 
transfection and the level of LC3-II and β-actin protein deter-
mined by western blot.
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obtained graphically for test genes and 18S internal stand-
ards. ΔCt values were calculated by subtracting 18S Ct
from test gene Ct, and average ΔCt values obtained from
duplicates. Relative mRNA levels were determined by sub-
traction of mock transfection ΔCt values from shVC/
shCSN2/shCSN5 ΔCt values to give a ΔΔCt value and con-
version through 2-ΔΔCt.
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